DEFISLESE - instructions for use, doses, side effects, contraindications

Active substanceHypromelloseHypromellose

Similar drugsTo uncover

Gipromelose-P

drops d / eye

Unimed Pharma s.r.o. The Slovak Republic

Hyperspace®

drops d / eye

SYNTHESIS, OJSC Russia

Artificial tear

drops d / eye

FIRN M, ZAO Russia

Dosage form: & nbspeye drops

Composition: Active substance: hypromellose (hydroxypropylmethylcellulose) - 3 mg

Excipients: Benzalkonium chloride, sodium chloride, disodium edetate (disodium ethylenediamine salt-N, N, N ', N'-tetraacetic acid 2-aqueous [Trilon B]), sodium dihydrogen phosphate dihydrate (sodium phosphate mono-substituted 2-hydroxy), sodium hydrogen phosphate dodehydrate sodium phosphate di-substituted 12-water), water for injection.

Description:

Transparent or slightly opalescent colorless or slightly colored liquid.

Pharmacotherapeutic group:Keratoprotective agent

ATX: & nbsp

S.01.X.A Other drugs for the treatment of eye diseases

S.01.X.A.20 Artificial tears and other indifferent drugs

Pharmacodynamics:The protector of the epithelium of the cornea, has a lubricating, softening effect with reduced secretion of tear fluid. Due to the high viscosity, the duration of contact of the drug with the cornea increases. The refractive index of the preparation is similar to a natural tear. Helps restore and stabilize the optical characteristics of tear film.Has a protective effect against the cornea with a decreased secretion of tear fluid and lengthens the action of other eye drops.

Pharmacokinetics:Data on the pharmacokinetics of the drug are absent.

Indications:

Lagoftalm, eyelid deformation, ectropion, condition after plastic surgery on the eyelids, thermal burns of the cornea and conjunctiva, keratoplasty and keratoectomy.

Bullous dystrophic changes of the cornea, erosion and trophic ulcers of the cornea, keratopathy, microdefects of the corneal epithelium, as part of the complex therapy of the "dry eye" syndrome.

Conducting gonioscopy, electroretinography, electrooculography, echobiometry.

Contraindications:

Hypersensitivity to the drug components, acute phase of chemical burn of the cornea and conjunctiva (until the complete removal of toxic substances or necrotic tissues), pregnancy and lactation.

Carefully:

In children under 18, the drug should be used only if the expected benefit exceeds the possible risk.

Pregnancy and lactation:

It is not recommended to use the drug during pregnancy.

If it is necessary to prescribe the drug during lactation, breastfeeding should be stopped.

Dosing and Administration:

Locally. 1 or 2 drops 4-8 times a day in the lower conjunctival sac, if necessary, 1 or 2 drops every hour. The course of treatment - at least 2-3 weeks.

When carrying out gonioscopy, electroretinography, electrooculography, echobiometric examination of the eyeball, one drop is once instilled.

Side effects:

Allergic reactions, the feeling of gluing the eyelids (due to the high viscosity of the solution), blurring of vision immediately after instillation, burning. in the eye, eye irritation.

Overdose:

Data on an overdose of the drug Defisles® are absent.

Interaction:

Do not use simultaneously with eye drops containing metal salts.

Special instructions:

Contact lenses are removed before the instillation of the drug and set again no earlier than 30 minutes after instillation.

Effect on the ability to drive transp. cf. and fur:

In the event of blurring of vision after instillation, it is necessary to refrain from driving vehicles and practicing potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions, before it is restored.

Form release / dosage:

Eye drops 3 mg / ml.

Packaging:

To 5 ml or 10 ml in bottles with a nozzle-dispenser and a cap screwed from plastic. 1 a plastic bottle with instructions for use is placed in a pack of cardboard.

Storage conditions:

In the dark place at a temperature of no higher than 25 ° C. Do not freeze. Keep out of the reach of children.

Shelf life:2 years. After opening the vial, use within 1 month.

Do not use after the expiration date.

Terms of leave from pharmacies:Without recipe

Registration number:LS-000198

Date of registration:18.02.2010 / 11.04.2012

Expiration Date:Unlimited

The owner of the registration certificate:SYNTHESIS, OJSC SYNTHESIS, OJSC Russia

Manufacturer: & nbsp

SYNTHESIS, OJSC Russia

Representation: & nbspSYNTHESIS JSC Joint-Stock Kurgan Society of Medical Preparations and Products SYNTHESIS JSC Joint-Stock Kurgan Society of Medical Preparations and Products Russia

Information update date: & nbsp27.03.2017

Illustrated instructions

Instructions

Hyperspace® (Defislez)